Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual ...
Individuals with asthma and chronic obstructive pulmonary disease (COPD) were more vulnerable than healthy controls to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback